EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved in the production, marketing, and sale of medicines related to human health and veterinary medicines. The Real Estate Development segment develops real estate properties; engages… Read more
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS (ECILC) - Net Assets
Latest net assets as of September 2025: TL57.41 Billion TRY
Based on the latest financial reports, EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS (ECILC) has net assets worth TL57.41 Billion TRY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (TL70.69 Billion) and total liabilities (TL13.28 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | TL57.41 Billion |
| % of Total Assets | 81.22% |
| Annual Growth Rate | -25.82% |
| 5-Year Change | 749.78% |
| 10-Year Change | 1538.2% |
| Growth Volatility | 81.91 |
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS - Net Assets Trend (2000–2024)
This chart illustrates how EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS (2000–2024)
The table below shows the annual net assets of EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | TL44.89 Billion | -10.78% |
| 2023-12-31 | TL50.31 Billion | +168.28% |
| 2022-12-31 | TL18.75 Billion | +153.57% |
| 2021-12-31 | TL7.40 Billion | +40.01% |
| 2020-12-31 | TL5.28 Billion | +23.50% |
| 2019-12-31 | TL4.28 Billion | +6.99% |
| 2018-12-31 | TL4.00 Billion | +14.86% |
| 2017-12-31 | TL3.48 Billion | +7.28% |
| 2016-12-31 | TL3.24 Billion | +18.41% |
| 2015-12-31 | TL2.74 Billion | -0.76% |
| 2014-12-31 | TL2.76 Billion | -5.45% |
| 2013-12-31 | TL2.92 Billion | +0.46% |
| 2012-12-31 | TL2.91 Billion | +11.07% |
| 2011-12-31 | TL2.62 Billion | +9.63% |
| 2010-12-31 | TL2.39 Billion | +9.00% |
| 2009-12-31 | TL2.19 Billion | +26.50% |
| 2008-12-31 | TL1.73 Billion | +3.25% |
| 2007-12-31 | TL1.68 Billion | +37.43% |
| 2006-12-31 | TL1.22 Billion | +29.03% |
| 2005-12-31 | TL945.68 Million | +75.26% |
| 2004-12-31 | TL539.60 Million | -100.00% |
| 2003-12-31 | TL436.00 Trillion | +335.64% |
| 2002-12-31 | TL100.08 Trillion | +106.42% |
| 2001-12-31 | TL48.48 Trillion | -16.85% |
| 2000-12-31 | TL58.31 Trillion | -- |
Equity Component Analysis
This analysis shows how different components contribute to EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 99.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | TL26.43 Billion | 58.89% |
| Other Components | TL18.45 Billion | 41.11% |
| Total Equity | TL44.88 Billion | 100.00% |
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS Competitors by Market Cap
The table below lists competitors of EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Westaim Corp
V:WED
|
$414.98 Million |
|
Luyin Investment Group Co Ltd
SHG:600784
|
$414.99 Million |
|
EL.En. S.p.A
OTCGREY:ELEAF
|
$415.27 Million |
|
Episil Holding
TWO:3707
|
$415.29 Million |
|
SANLORENZO IN SIGLA SL
F:6SZA
|
$414.85 Million |
|
Suzhou Huaya Intelligence Technology Co Ltd
SHE:003043
|
$414.82 Million |
|
Healthcare Co Ltd
SHG:603313
|
$414.76 Million |
|
Ucap Cloud Information Technology Co Ltd
SHG:688228
|
$414.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 50,307,880,000 to 44,884,087,000, a change of -5,423,793,000 (-10.8%).
- Net income of 1,023,611,000 contributed positively to equity growth.
- Dividend payments of 935,975,000 reduced retained earnings.
- Other factors decreased equity by 5,511,429,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | TL1.02 Billion | +2.28% |
| Dividends Paid | TL935.98 Million | -2.09% |
| Other Changes | TL-5.51 Billion | -12.28% |
| Total Change | TL- | -10.78% |
Book Value vs Market Value Analysis
This analysis compares EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.75x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 22.52x to 1.75x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | TL5.08 | TL114.40 | x |
| 2018-12-31 | TL5.83 | TL114.40 | x |
| 2019-12-31 | TL6.24 | TL114.40 | x |
| 2020-12-31 | TL7.71 | TL114.40 | x |
| 2021-12-31 | TL10.79 | TL114.40 | x |
| 2022-12-31 | TL27.36 | TL114.40 | x |
| 2023-12-31 | TL73.41 | TL114.40 | x |
| 2024-12-31 | TL65.50 | TL114.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.28%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.68%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 1.25x
- Recent ROE (2.28%) is below the historical average (6.54%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 7.00% | 3.87% | 0.83x | 2.17x | TL-1.75 Trillion |
| 2005 | 3.95% | 4.34% | 0.65x | 1.40x | TL-56.29 Million |
| 2006 | 3.02% | 3.66% | 0.57x | 1.44x | TL-83.84 Million |
| 2007 | 27.21% | 50.78% | 0.43x | 1.26x | TL285.56 Million |
| 2008 | 4.19% | 8.93% | 0.40x | 1.18x | TL-99.65 Million |
| 2009 | 13.37% | 33.18% | 0.35x | 1.15x | TL73.13 Million |
| 2010 | 2.55% | 6.61% | 0.34x | 1.12x | TL-176.47 Million |
| 2011 | 3.40% | 9.09% | 0.32x | 1.17x | TL-171.60 Million |
| 2012 | 1.14% | 3.01% | 0.31x | 1.22x | TL-253.28 Million |
| 2013 | 2.13% | 5.45% | 0.33x | 1.19x | TL-226.71 Million |
| 2014 | -1.58% | -4.14% | 0.32x | 1.19x | TL-317.68 Million |
| 2015 | 2.47% | 5.78% | 0.35x | 1.23x | TL-205.97 Million |
| 2016 | 5.68% | 13.08% | 0.35x | 1.23x | TL-140.27 Million |
| 2017 | 4.20% | 24.43% | 0.16x | 1.10x | TL-201.96 Million |
| 2018 | 6.01% | 34.69% | 0.16x | 1.11x | TL-159.66 Million |
| 2019 | 3.80% | 18.55% | 0.18x | 1.13x | TL-264.99 Million |
| 2020 | 6.10% | 35.43% | 0.15x | 1.13x | TL-206.14 Million |
| 2021 | 10.21% | 68.42% | 0.13x | 1.12x | TL15.49 Million |
| 2022 | 22.28% | 228.22% | 0.08x | 1.24x | TL2.30 Billion |
| 2023 | 7.86% | 42.28% | 0.15x | 1.25x | TL-1.08 Billion |
| 2024 | 2.28% | 11.68% | 0.16x | 1.25x | TL-3.46 Billion |
Industry Comparison
This section compares EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $673,401,893
- Average return on equity (ROE) among peers: 12.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS (ECILC) | TL57.41 Billion | 7.00% | 0.23x | $414.89 Million |
| Deva Holding AS (DEVA) | $411.91 Million | 2.12% | 1.17x | $61.08 Million |
| Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) | $1.28 Billion | 24.20% | 0.65x | $69.84 Million |
| Turk Ilac ve Serum Sanayi AS (TRILC) | $324.08 Million | 11.46% | 0.91x | $34.30 Million |